Reuters logo
6 months ago
BRIEF-Holy Stone Healthcare receives patent for Hyaluronic acid conjugated drugs
February 3, 2017 / 1:39 AM / 6 months ago

BRIEF-Holy Stone Healthcare receives patent for Hyaluronic acid conjugated drugs

1 Min Read

Feb 3(Reuters) - Holy Stone Healthcare Co Ltd

* Says it receives patent for HACD (Hyaluronic acid conjugated drugs)which will be used for the treatment of colorectal cancer, glioblastoma, from United States Patent and Trademark Office

Source text in Chinese:goo.gl/0lghDa

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below